Delivery Order SPE2DB20D2002-SPE2DB25FL58N
Award Date 7/22/25
Potential Completion Date 7/23/25
Potential Value $35K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,870.10 on August 4, 2025, for the supply of IPOL Vial 5ML pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $41,480.40 to AmerisourceBergen Drug Corp on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $82,029.40 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,575.92 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price, competitively awarded delivery order was issued under a non-set-aside procurement to the pharmaceutical distributor's Corporate Office division, based in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $40,724.84 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through competitive procurement and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,154.50 Firm Fixed Price delivery order contract is for the supply of 4567301266 IPOL VIAL 5ML medical products. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,192.65 to AmerisourceBergen Drug Corp on July 28, 2025, with a completion date of July 29, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $111,086.64 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitive award, which carries no set-aside designation, is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,677.88 to AmerisourceBergen Drug Corp for the supply of IPOL Vial 5ML pharmaceutical products. This firm fixed-price, competitively awarded delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating AmerisourceBergen Drug Corp...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,585.30 to AmerisourceBergen Drug Corp on August 12, 2025, with a completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The delivery order was placed with AmerisourceBergen's...